October 29, 2018 Clinical Research/Diagn. M&A, Partnerships

MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology

PDF Version Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013 SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that MacroGenics(NASDAQ:MGNX) and NanoString have entered into a translational research agreement to identify and develop biomarkers for MacroGenics’ MGD013 program.... Read more

October 29, 2018 Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins Thermo Fisher and Symphogen to develop new workflows to characterize and monitor the quality of mixed antibody products SUNNYVALE, Calif., Oct. 29, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into... Read more

October 25, 2018 M&A, Partnerships

Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD

WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The... Read more

October 25, 2018 Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD

WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The... Read more

October 25, 2018 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System

PDF Version Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technology, today announced the publication of the 10,000 Immunomes Project (10KIP), a seminal human immune reference standard containing mass cytometry immune cell profiles,... Read more

October 25, 2018 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare and Shirazi Trading host continuous educational workshops for Pakistan’s leading cardiologists and radiologists

Islamabad, Pakistan; October 08, 2018: GE Healthcare (NYSE: GE), in collaboration with Shirazi Trading, held a series of Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Imaging workshops in Rawalpindi, Pakistan. The workshops, led by renowned cardiologist Dr. Saima Mushtaq, GE Healthcare’s Clinical Leaders for CT and MRI, Murat Karakoc and Dr. Ibrahim Elmogy, brought... Read more

October 23, 2018 Life Science Tools M&A, Partnerships

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

Vienna, Austria, October 23, 2018 /PRNewswire/ – RNA (ribonucleic acid) is one of the most important building blocks of life, and this molecule is researched in diverse biological disciplines. In 2016, the RNA Society launched the “RNA Salon” program to cultivate interactions between RNA researchers who might be regionally close but belong to various departments or... Read more

October 22, 2018 Clinical Research/Diagn. M&A, Partnerships

Quanterix Announces Collaboration With Oncogenesis to Develop Cervical Screening Test

OCTOBER 22, 2018 Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection Lexington, Mass. – October 22, 2018 — Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening company, to develop a quantitative, protein... Read more

October 22, 2018 Clinical Research/Diagn. M&A, Partnerships

Announcement of Participation in AMED Project “Research and development of core technologies for gene and cell therapy”

2018/10/22 Kusatsu/Shiga, Japan — October 22, 2018 – Takara Bio Inc. announces that it is participating in “Research and development of core technologies for gene and cell therapy” (Project) undertaken by Japan Agency for Medical Research and Development (AMED: https://www.amed.go.jp/en/index.html) since FY2018, under which Takara Bio will work on the development for large-scale production technologies of... Read more

October 22, 2018 Environ, Ag./Food & Bev Informatics & Software Life Science Tools M&A, Partnerships

NRGene and Kayagene, LLC Collaborate to Improve Cannabis Breeding and Seed Production

Revealing the complete genome makeup of multiple varieties resolves the genetic basis of key traits Ness Ziona, Israel, and Salinas, Calif. (Oct 22, 2018)– Kayagene, an innovative cannabis breeding company, and NRGene, the leading agricultural genomics company, are collaborating on research to enhance Kayagene’s breeding capabilities  to develop improved cannabis varieties and more robust seed production. The non-exclusive... Read more